Asterion will be developing the largest and most sophisticated state-of-the-art medicinal cannabis cultivation, research and manufacturing facility in the developed world. The 75-hectare site will consist of ~40 hectares of glasshouse cultivation, a research center and onsite GMP manufacturing for the company’s end product.
Asterion is committed to reducing its’ carbon footprint at every opportunity. The design includes optimization for environmental sustainability, including water-saving and practices that reflect the environmental expectations of the Toowoomba Regional Council and broader Toowoomba community.
The glasshouses will be built out in three phases: 1st Phase – 10 ha; 2nd Phase – 10 ha; and 3rd Phase – 20 ha with the facility’s expected outputs, upon completion, to exceed 500,000 kg per annum.
Operations development are under the direction of one of the most experienced cannabis start-up and operations teams with an extensive performance history building and operating cannabis cultivation and cannabis sales under strict government regulations.
Leadership experience in cannabis infrastructure is broad – from leading the SOP/QA process for four cannabis cultivation and three cannabis sales licensees to taking a tally of four cannabis companies public within the Canadian market.
The Australian federal government has granted Asterion Major Project Status which was announced in a Federal Press Release and has been listed on the government's Department of Industry, Innovation and Science business website and page for Current Major Projects.
The Queensland Premier and Cabinet are engaged with Asterion and have expressed excitement by the economic benefits the project may bring to Queensland.
These benefits will include substantial job growth opportunities in the form of up to 1500+ full and part-time jobs. Additionally, the project will bring advances in science and research which will in time attract further investment to the state.
The company was granted, in December 2020, a medicinal cannabis license, a cannabis research license, and a manufacture license from the Australian Department of Health, Office of Drug Control (ODC). Listing on the ODC can be found here.